DxWound: A DNA-Based Assessment of the Wound Microbial Environment

Webinar Overview
Date: Tuesday, Nov 14, 2017
Time: 10 AM PT / 1PM ET
Duration: 1 hour

Managing wound complications such as skin and soft tissue infections is a well-known challenge for clinicians.  Multiple interventions are typically required for optimal outcomes, and initiating the appropriate antimicrobial therapy for SSTIs within the first 48 hours is key. This program highlights the burden of infected wounds on patients and the healthcare system, explains the significance of antibiotic failure, particularly early in the course of therapy, and describes how DxWound provides a rapid, comprehensive assessment of the wound microbial environment, thus helping clinicians rapidly target antimicrobial therapy.

Objectives: Upon completion of this session participants will be able to:

  • Recognize the burden of infected wounds on patients and the healthcare system
  • Explain the significance of antibiotic failure, particularly early in the course of therapy
  • Describe how DxWound provides a rapid, comprehensive assessment of the wound microbial environment
  • Discuss how DxWound may help clinicians rapidly target antimicrobial therapy

Speakers: 

  • Sandy Estrada
    Pharm.D., BCPS (AQID)
    Lee Health
  • Brandon Adkins
    Pharm.D., MS, CSPI
    Millennium Health

Share: